Product Information
QELBREE ER 200 MG CAPSULE is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $12.7405 per EA under NDC 17772013360. Its NADAC has been published 206 times since Sep 14, 2022.
FDA first approved this application on Apr 2, 2021.
Strength
200 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772013360
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VILOXAZINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA211964FDA Approved
4/2/2021
On Market Since
4/2/2021
Pharmacological Classes
Price Statistics
The NADAC for QELBREE ER 200 MG CAPSULE has been published 206 times since Sep 14, 2022, and over the history we have for it it has risen 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.7405 per EA |
|---|---|
| All-time high | $12.7551 (May 13, 2026) |
| All-time low | $10.1043 (Sep 14, 2022) |
| 52-week high | $12.7551 |
| 52-week low | $12.0331 |
| Median price | $11.3719 |
| Average price | $11.5046 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 206 |
| Tracking since | Sep 14, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QELBREE ER 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QELBREE ER 200 MG CAPSULE, manufactured by Supernus Pharmaceuticals Inc., is $12.7405 per EA (NDC 17772013360), effective Aug 19, 2026.
How has the price of QELBREE ER 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QELBREE ER 200 MG CAPSULE has risen 26.1%. It has been tracked across 206 weekly CMS publications since Sep 14, 2022.
What are the highest and lowest recorded NADAC prices for QELBREE ER 200 MG CAPSULE?
Since Sep 14, 2022, the NADAC for QELBREE ER 200 MG CAPSULE has ranged from a low of $10.1043 (Sep 14, 2022) to a high of $12.7551 (May 13, 2026), with a median of $11.3719 per EA.
Are there cheaper alternatives to QELBREE ER 200 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QELBREE ER 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures QELBREE ER 200 MG CAPSULE?
QELBREE ER 200 MG CAPSULE (NDC 17772013360) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.